Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Super-resolution microscopy for immune checkpoint inhibitors diagnostics

Project description

Super-resolution microscopy for cancer diagnosis

Immunotherapy against cancer constitutes an in principle promising strategy with long-lasting therapeutic potential. However, clinical success has so far been limited. Funded by the European Research Council, the NANODIAGNOSTIC project proposes to stratify patients for immunotherapy as a way of predicting the clinical outcome. Researchers will use super-resolution microscopy tools previously developed for studying the mechanism of action of targeted therapies. Super-resolution microscopy encompasses fluorescence imaging techniques capable of reaching nanometer-scale resolution, facilitating the visualisation of single molecules. The introduction of this sensitive approach in cancer diagnosis is expected to improve the outcome of immunotherapy.

Objective

In the last decade, super-resolution microscopy techniques have emerged as powerful quantitative tools for biology. They have capabilities to visualize single molecules at the nanoscale opening the door to study biological processes at a level not accessible before. In the ERC StG NANOSTORM we showed the potential of these techniques providing new fundamental knowledge on the mechanism and design of new targeted therapies. However, some of the methods we developed have the potential to be translated into applied clinical diagnostic tools. In NANODIAGNOSTIC, we would offer a proof-of-concept of the application of super resolution microscopy and single-molecule imaging for cancer diagnostic, with a focus on patients stratification for immunotherapy. Novel advances in immunotherapies have brought the development of immune checkpoint inhibitors (ICI) that re-activate the immune system against the tumor. Despite the high success of these therapies there is one main challenge: they are only effective on a limited portion of patients and current diagnostic approaches are not capable of stratifying patient successfully. NANODIAGNOSTIC will translate advance optical methods from an academic setting to the clinic and holds a great potential to provide new diagnostic methods to improve the outcome of immunotherapy.

Fields of science (EuroSciVoc)

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC-POC - HORIZON ERC Proof of Concept Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2022-POC2

See all projects funded under this call

Host institution

TECHNISCHE UNIVERSITEIT EINDHOVEN
Net EU contribution
€ 150 000,00
Address
GROENE LOPER 3
5612 AE Eindhoven
Netherlands
Region
Zuid-Nederland Noord-Brabant Zuidoost-Noord-Brabant
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Beneficiaries (1)